Add to ORKGSecond generation antipsychotics are widely used in the treatment of psychotic disorders, and has been linked to devel-opment of metabolic syndrome. Aripiprazole is a atypical antipsychotic with a novel mechanism of action and has been generally found to be least linked with the development of metabolic complications, such as obesity, diabetes and hyper-lipedemia.We present a case report of a patient on aripiprazole who developed obesity and diabetes mellitus after initia-tion of aripiprazole (German J Psychiatry 2010; 13: 49-50)
As an example of iatrogenic diabetes, we discuss the problem of diabetes mellitus in patients receiv...
Background: Second-generation antipsychotic medications, such as Aripiprazole (Abilify) and Olanzap...
Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hy...
Atypical antipsychotics is known to cause a number of adverse metabolic effects, including weight ga...
Context Atypical antipsychotic agents are associated with diabetes mellitus and pancreatitis. Aripip...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing ...
Second-generation (atypical) antipsychotic medications are of great benefit to a wide variety of peo...
Metabolic syndrome can contribute to significant morbidity and premature mortality and should be acc...
editorial reviewedPsychotropic drugs may be associated with metabolic disorders, often but not only ...
Abstract Introduction People with schizophrenia are at increased risk of developing metabolic distur...
Metabolic syndrome can contribute to significant morbidity and premature mortality and should be acc...
Atypical antipsychotic (AAP) medications that have revolution-ized the treatment of mental illness h...
Aripiprazole is a novel antipsychotic with a unique pharmacological profile as a dopamine partial ag...
As an example of iatrogenic diabetes, we discuss the problem of diabetes mellitus in patients receiv...
Background: Second-generation antipsychotic medications, such as Aripiprazole (Abilify) and Olanzap...
Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hy...
Atypical antipsychotics is known to cause a number of adverse metabolic effects, including weight ga...
Context Atypical antipsychotic agents are associated with diabetes mellitus and pancreatitis. Aripip...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing ...
Metabolic abnormalities occur frequently in patients treated with antipsychotics and are of growing ...
Second-generation (atypical) antipsychotic medications are of great benefit to a wide variety of peo...
Metabolic syndrome can contribute to significant morbidity and premature mortality and should be acc...
editorial reviewedPsychotropic drugs may be associated with metabolic disorders, often but not only ...
Abstract Introduction People with schizophrenia are at increased risk of developing metabolic distur...
Metabolic syndrome can contribute to significant morbidity and premature mortality and should be acc...
Atypical antipsychotic (AAP) medications that have revolution-ized the treatment of mental illness h...
Aripiprazole is a novel antipsychotic with a unique pharmacological profile as a dopamine partial ag...
As an example of iatrogenic diabetes, we discuss the problem of diabetes mellitus in patients receiv...
Background: Second-generation antipsychotic medications, such as Aripiprazole (Abilify) and Olanzap...
Antipsychotic medications can induce cardiovascular and metabolic abnormalities (such as obesity, hy...